Navigation Links
Abbott to Acquire Evalve, Inc., a Leader in Minimally Invasive Cardiac Valve Repair Technology
Date:9/10/2009

ABBOTT PARK, Ill. and MENLO PARK, Calif., Sept. 10 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) announced today a definitive agreement to acquire the outstanding equity of Evalve, Inc., the global leader in the development of devices for minimally invasive repair of cardiac mitral valves. The acquisition provides Abbott with a presence in the growing area of non-surgical treatment for structural heart disease, in which physicians use catheter-based devices to repair or replace basic structural components of the heart such as mitral and aortic valves. The agreement includes an upfront payment of $320 million in cash, plus an additional payment upon completion of certain regulatory milestones, for a total of up to $410 million.

"The acquisition of Evalve will provide Abbott with leading technology in the emerging field of minimally invasive heart valve repair and further broadens Abbott's medical devices portfolio," said John M. Capek, Ph.D., executive vice president, Medical Devices, Abbott. "Evalve is on the cutting edge with its non-surgical approach to treating structural heart disease. With this breakthrough mitral valve repair technology, physicians will be able to offer their patients a minimally invasive alternative to open heart surgery -- not unlike the opportunity that stents provided more than two decades ago for the treatment of coronary artery disease."

Mitral regurgitation, a condition that prevents the mitral valve from closing completely, is the most common type of heart valve insufficiency in Europe and the United States, and affects millions of people worldwide. Traditionally, mitral regurgitation is treated through open heart surgery. However, only about 20 percent of the 600,000 patients diagnosed in the U.S. and Europe each year undergo surger
'/>"/>

SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Abbott Expands XIENCE V(R) USA Trial to Enroll Patients into Landmark Dual Anti-Platelet Therapy (DAPT) Trial
2. Abbott HIV Test Demonstrates Earlier Disease Detection
3. Centocor Ortho Biotech Inc. Awarded $1.67 Billion Patent Jury Verdict from Abbott Laboratories
4. Abbott & BioGenex Extend the Technology Co-development and Distribution Agreement for Marketing the Xmatrx(R) Advanced Staining Platform for the Automation of FISH, IHC and ISH Molecular Diagnostic Assays
5. Abbott Named One of the Top 10 Companies for Scientists
6. HUYA Bioscience Announces Strategic Alliance With Abbott on Drug and Biomarker Development Candidates From China
7. Abbott to Present at Barclays Global Healthcare Conference
8. Abbott Employee Giving Sets New Records for Employee Participation and Total Donations
9. Abbott Announces 11 Percent Increase in Quarterly Dividend
10. Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO)
11. Abbott Announces Earnings Guidance for 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Ind. -- Chemists at Indiana University Bloomington have ... bricks-and-mortar fashion, a development with potential value for ... field-effect transistors and photovoltaic cells. , Their paper, ... Crystalline Solids and 2D Self-Assembled Crystals," has been ... journal of the Royal Society of Chemistry. It ...
(Date:7/31/2014)... Rogne Bioscience, a privately-held biotechnology company based ... has acquired a licence to anti-inflammatory peptides from Isis ... anti-inflammatory activity of the peptides was discovered by Professor ... Sir William Dunn School of Pathology. ... million in seed financing, is developing a first-in-class, topical ...
(Date:7/31/2014)... ALBANY, New York , July 31, 2014 /PRNewswire/ ... published by Transparency Market Research "Electrodes for Medical Devices ... Fetal Scalp Electrodes, Therapeutic Electrodes - TENS, Pacemakers, Defibrillators, ... Share, Growth, Trends and Forecast, 2013 - 2019," the ... USD 633.6 million in 2012 and is estimated to ...
(Date:7/31/2014)... Senomyx , Inc. (NASDAQ: ... taste science technologies to discover, develop, and commercialize ... ingredient supply industries, today reported financial results for ... second quarter with $33.6 million in cash and ... past quarter Senomyx achieved another important milestone with ...
Breaking Biology Technology:Chemists demonstrate 'bricks-and-mortar' assembly of new molecular structures 2Chemists demonstrate 'bricks-and-mortar' assembly of new molecular structures 3Oxford licenses anti-inflammatory peptides to San Francisco Bay Area start-up 2Oxford licenses anti-inflammatory peptides to San Francisco Bay Area start-up 3Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research 2Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research 3Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research 4Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research 5Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research 6SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 14SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 15SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 16
... and Mass Spectrometry Application Note , ... Mass Frontier , Mark R. ... Introduction , ... development. In the early discovery phase, studies are designed to help the ...
... , I. Introduction ... note describes assay conditions for screening GPCR agonists on a ... miniaturized platform results in low cell and reagent consumption, high ... microfluidic assay accesses test compounds from a microtiter plate and ...
... Mike Benway, Larry Simonson and John Ung , ... Applications Laboratory, Hopkinton, Massachusetts, USA , ... "Assay-Ready" plates prepared from compound or library stock plates in real ... to transfer and dilute 0.5μL volumes is a prerequisite for this ...
Cached Biology Technology:Analysis of a Verapamil Microsomal Incubation using Metabolite ID and Mass FrontierTM 2Analysis of a Verapamil Microsomal Incubation using Metabolite ID and Mass FrontierTM 3Analysis of a Verapamil Microsomal Incubation using Metabolite ID and Mass FrontierTM 4Analysis of a Verapamil Microsomal Incubation using Metabolite ID and Mass FrontierTM 5Analysis of a Verapamil Microsomal Incubation using Metabolite ID and Mass FrontierTM 6Analysis of a Verapamil Microsomal Incubation using Metabolite ID and Mass FrontierTM 7Analysis of a Verapamil Microsomal Incubation using Metabolite ID and Mass FrontierTM 8Analysis of a Verapamil Microsomal Incubation using Metabolite ID and Mass FrontierTM 9Analysis of a Verapamil Microsomal Incubation using Metabolite ID and Mass FrontierTM 10HEK293 Calcium Flux Assay 2HEK293 Calcium Flux Assay 3HEK293 Calcium Flux Assay 4HEK293 Calcium Flux Assay 5Dispensing 0.5μL to "Dry" 384 Plates with the Sciclone ALH 2Dispensing 0.5μL to "Dry" 384 Plates with the Sciclone ALH 3
(Date:7/31/2014)... fat cells, are inherently different. Each of these cell ... role in metabolism. In the human body, white adipose ... function is energy storage. On the other hand, brown ... only found in a few places in the adult ... of brown adipocytes, appear mixed with brown adipocytes in ...
(Date:7/30/2014)... New York University is paving the way for ... civilians and military troops exposed to poisonous chemicalsparticularly ... An article in the current issue of the ... detoxifying organophosphates, which are compounds commonly used in ... developed by NYU School of Engineering Associate Professor ...
(Date:7/30/2014)... studying the potential effects of climate change on ... on the wrong factors, according to a new ... Conservation Society, University of Queensland, and other organizations. ... science is missing the point when it comes ... of climate change scientists focus on the "direct" ...
Breaking Biology News(10 mins):Hope for the overweight 2Engineering a protein to prevent brain damage from toxic agents 2Conservation scientists asking wrong questions on climate change impacts on wildlife 2
... Automation and Electrical Systems , a new journal in partnership ... Controle and Automao , the new journal will publish ... on Springer,s online platform, SpringerLink . The ... industrial automation, addressing such topics as circuits and systems; control ...
... the Journal of Visualized Experiments , will publish two ... growth. The methods introduce a lab-born, human tissue ... opportunity to grow, observe, and ultimately learn how to ... of Wrzburg scientists behind the experiment have created a ...
... shown great success in treating many patients with lung, breast, ... means that many other patients do not respond, and even ... A new study from MIT reveals that much of this ... to circumvent the effects of ErbB inhibitors, allowing them to ...
Cached Biology News:Journal of Control, Automation and Electrical Systems now published by Springer 2Cancer research implies future for personalized medicine, reduction in animal testing 2Why tumors become drug-resistant 2Why tumors become drug-resistant 3
... S&S Custom Processing Service enables scientists who do ... data analysis software to have their biological samples ... analytes. Its as easy as 1-2-3 ... in your samples from the S&S antibody menu. ...
... 2) Dot plot, Contour plot, Density Plot, ... 4) Cell Cycle 5) Analysis Platform ... generation of graphs and statistics 8) Advanced ... to perform complex batch analyses 10) Exporting ...
... synthetic peptide whose sequence is derived from bovine rhodopsin protein. ... terminus): C - S(338) - K - T - ... A - P - A(348). This peptide may ... antibody that reacts with this product and bovine rhodopsin, catalog ...
... Dual-Binary Analytical System more than doubles the ... LC/MS. The fast analysis cycles of the ... to 100% in tandem mode. Difficult separations ... Using backflush or heartcut configurations, on-line sample ...
Biology Products: